Advertisement
<< Back To Article
Injectable Long-Acting Cabotegravir Shows Promise As PrEP in Early Safety Trial

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

cinciskeet

Why oh why is this study just for gay men? For too long testosterone has been testing drugs that estrogen uses when the drug goes to the pipeline. I see this as a form of discrimination.

May 16, 2016 Ohio

Advertisement

Hot topics